GYKI 23107

structure given in first source

Also Known As:

1-(2,6-dimethylphenylamino)-2-dimethylaminopropane; GYKI-23107

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Ventricular Fibrillation 01/01/1988 - "In this lidocaine-treated group, ventricular fibrillation could be produced at 27.7 +/- 6.6 (S.D.) min, n = 12, while after GYKI-23107 ventricular fibrillation occurred at 46.6 +/- 10.7 min, n = 14. "

1.	Lidocaine (Xylocaine)